Trade Mark Journal No.2021/053 31 December 2021

WO0000001630874 (42)

Office of origin: United States of America

Date of International Registration:18 October 2021
Date of designation in the UK: 18 October 2021
Image for mark 1630874

The mark consists of the wording BOREALIS in stylized lettering and the design of three different-sized triangles superimposed over one another and positioned facing rightward, with the forewardmost triangle being shaded in green, the middle-ground triangle being shaded in blue, and the rear triangle being shaded in purple, and the color of the most western side of each triangle fading into a non-distinct edge.

The color(s) green, blue, and purple is/are claimed as a feature of the mark.

The mark consists of the wording BOREALIS in stylized lettering and the design of three different-sized triangles superimposed over one another and positioned facing rightward, with the forewardmost triangle being shaded in green, the middle-ground triangle being shaded in blue, and the rear triangle being shaded in purple, and the color of the most western side of each triangle fading into a non-distinct edge.

International priority date claimed: 19 May 2021 (United States of America) (90720612)
Class 42
Pharmaceutical product development and evaluation; research in the field of pharmaceuticals; testing of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials.

Dicerna Pharmaceuticals, Inc.

Representative: Glenn A. Gundersen Dechert LLP, 2929 Arch Street, Cira Centre, Philadelphia PA 19104-2808, UNITED STATES OF AMERICA